In the Clinic: Triple Combination CFTR Modulation

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/93/80/a3/9380a3e6-8135-ddbc-2128-1011bf954bd7/mza_3707003826622290779.jpeg/600x600bb.jpg

eCysticFibrosis Review

72 episodes

8 months ago

Expert insight and analysis providing information directly relevant to cystic fibrosis care, through topic-focused newsletters summarizing the peer-reviewed literature and accompanying podcasts to illustrate how to apply that information in the clinic.

Hosted on Acast. See acast.com/privacy for more information.

All content for eCysticFibrosis Review is the property of eCysticFibrosis Review and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hosted on Acast. See acast.com/privacy for more information.

Medicine

Education,

Health & Fitness

https://assets.pippa.io/shows/5fa6e32f007fe14c6dd46501/1606333859754-916d0970df0004edac1a1fcf7559a3c0.jpeg

In the Clinic: Triple Combination CFTR Modulation

eCysticFibrosis Review

25 minutes 17 seconds

5 years ago

In the Clinic: Triple Combination CFTR Modulation

Elexacaftor/tezacaftor/ivacaftor — the newly approved triple combination CFTR modulator therapy. What are the benefits? For which patients? What are the potential adverse effects? Who’s most likely to receive them?

In this issue, Dr. Scott Sagel from the Breathing Institute at the Children’s Hospital Colorado, part of the University of Colorado’s Anschutz Medical Campus, takes us to the clinic to discuss some answers.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.